IMPILO
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
IMPILO
Social Links:
Industry:
Financial Services Health Care Venture Capital
Founded:
2017-01-01
Status:
Active
Contact:
+46 8 401 00 60
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-20 | Scantox | Scantox acquired by Impilo | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-01-26 | Scantox | Impilo investment in Venture Round - Scantox | N/A |
| 2018-02-27 | Cavidi | Impilo investment in Venture Round - Cavidi | 11.5 M USD |
More informations about "Impilo"
Impilo at a glance - Impilo
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”), well recognized for its high-quality genetic toxicology …See details»
Impilo - Crunchbase Investor Profile & Investments
Impilo is an investment company that invests in companies operating in the pharmaceutical, med tech, and other health-related industries.See details»
Meet the team - Impilo
Prior to founding Impilo, Fredrik was a partner at Altor, a firm he co-founded in 2003. 1989-1996 and 1999-2002 Fredrik worked at Goldman Sachs International, the last period as managing …See details»
Impilo has closed its second investment pool - Impilo
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”), well recognized for its high-quality genetic toxicology …See details»
Impilo - Crunchbase Company Profile & Funding
Impilo is a developer of digital health operating systems aimed at improving the infrastructure underlying remote healthcare. Through its full-stack middleware technology, the company's systems provide an e-commerce and application …See details»
Impilo - Funding, Financials, Valuation & Investors
Impilo provides remote care logistics and patient support solutions.See details»
ImpiloVest | Wellness, Source To Shelf | Official Website
We at Impilovest are committed to sourcing and creating opportunities that expand access to high quality health solutions.See details»
Impilo - Cision News
Jun 21, 2017 Scantox A/S (“Scantox” or the “Company”), the leading Nordic GLP-compliant pre-clinical contract research organization (“CRO”), headquartered in Denmark and since 2021 …See details»
Impilo | Child Protection and Adoption Services
Impilo, a designated child protection organisation with adoption accreditation for national and intercountry adoptions, places children in temporary safe care while carrying out intensive social work and child protection services so that children …See details»
Impilo acquires Qufora in partnership with existing shareholders
Sep 9, 2024 Impilo is now the majority shareholder in the Danish medtech company Qufora, which produces clinical aids for patients with chronic bowel conditions. This partnership will …See details»
Impilo | Remote Patient Monitoring Devices
Impilo provides API infrastructure for patient monitoring and connected supplies. Our platform enables the ability to buy, distribute, support, and integrate digital health devices/supplies. Impilo handles patient monitoring operations, while …See details»
Healthcare is always evolving, so are we. Impilo has rebranded!
At Impilo, we are redefining healthcare delivery by enabling high-quality care directly to patients, wherever they may be. We simplify virtual care operations, educate patients, and empower …See details»
The Comprehensive Features of the Impilo API
In the world of healthcare technology, simple integration and real-time data exchange are crucial. When it comes to choosing between using the Impilo API or a device manufacturer's API for …See details»
News - Impilo
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”), well …See details»
Impilo has closed its second investment pool - Cision News
Sep 16, 2021 Impilo is an investment company focused on investments in Nordic healthcare companies active in the pharmaceutical, medical devices, care services and other health …See details»
Impilo Pharmaceutical - Crunchbase Company Profile & Funding
Impilo Therapeutics, Inc. The combination expands Cend’s drug delivery capabilities to create a unique platform for targeted tissue penetrating delivery of nucleic acid-based medicines to …See details»
ABOUT US - impilomedia
Impilo would be there to positively influence young adults through pop-culture. As Impilo grew, it became apparent that the organization’s strength lay in its ability to create media that …See details»
KKR and Impilo announce strategic partnership together with …
KKR and Impilo announce strategic partnership together with management in rare disease platform Immedica Pharma Investment funds managed by KKR, a leading global investment …See details»
Sustainability Report for 2021 - Impilo
Sep 9, 2024 Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization …See details»
Impilo | Solutions
Join us for our webinar on December 19th to prepare for the 2025 CPT billing changes!Empowering remote care with digital health solutions.See details»